– GEN’s Editor-in-Chief John Sterling interviews Richard Canady, Ph.D., DABT, Senior Health Scientist, U.S. Food and Drug Administration, about the FDA’s Task Force Report on Nanotechnology

PodcastsResourcesHealth care and economicsHealth care facility, manpower, and servicesHealth care organizationsNanotechnologyTechnology and Computational BiologyUnited States Food and Drug Administration
Previous articleResearchers Find Enzyme’s Role in the Regulation of Good Cholesterol
Next articleLilly Facility Expansion Inaugurated in Puerto Rico
Also of Interest
Visual Proteomics: Observing Protein Location in Living Cells
Bruker to Acquire NanoString with $392.6M Winning Bid
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
Viral RNA-Based Diagnostics: Nanopore System May Outperform PCR
Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo
Flipping the Script: Atomwise AI Platform Presents an Alternative to High Throughput Screening
Related Media
Genetics in DC: A Report from ASHG
Carl Icahn States His Case for Change at Illumina on "Close to the Edge"
Emerging Markets Collaborate to Succeed in Post-Pandemic World
Global Single-Use Network Support Assurance of Supply
Reporter's Notebook: Opening Day at the J.P. Morgan Healthcare Conference
Mechanistic Modeling Improves Drug Discovery Workflows and Speeds Therapeutic Development